Redx Pharma previews plans for idiopathic pulmonary fibrosis and Crohn's disease

CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.

Related Keywords

Jane Robertson ,Redx Pharma ,Centric Services For ,Laboratory Equipment ,Contract Research Services For Clinical Trial ,Drug Processing Technology ,Clinical Trial Database ,Clinical Trials ,Processing Technology ,Centric Services ,Alternate Site Clinical Trials ,Research Services ,Clinical Trial ,